Skip to content

Oklo OKLO Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

BWX Technologies logo
BWX TechnologiesBWXT
Vistra logo
VistraVST
ALN
Alnylam PharmaceuticalsALNY
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Operating income-$51.2M-187%
Net income-$33.1M-237%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$15.6M+233%
Total debt$2.6M+46.1%
Total equity$2.6B+880%
Total assets$2.7B+795%

Cash flow

See full
Operating cash flow-$17.9M-45.9%
CapEx$32.8M+9,783%
Free cash flow-$50.7M-303%

Valuation

See full
Market cap$10.64B+186%
Enterprise value$10.63B+186%

Returns & leverage

See full
Return on equity-8.9%
Debt / equity0.0×
Current ratio59.9×+23.7×

Where this comes from

Reported directly by Oklo in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: Oklo’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oklo's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oklo's preferred stock, shares authorized?
Oklo (OKLO) reported preferred stock, shares authorized of $1M in Q1 2026.